Literature DB >> 20232122

Clinical aspects and genetic analysis of taiwanese patients with wiskott-Aldrich syndrome protein mutation: the first identification of x-linked thrombocytopenia in the chinese with novel mutations.

Wen-I Lee1, Jing-Long Huang, Tang-Her Jaing, Kang-Hsi Wu, Yin-Hsiu Chien, Kuei-Wen Chang.   

Abstract

BACKGROUND: Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency characterized by microthrombocytopenia, eczema, and recurrent infections. However, the more than 500 patient mutations described are mainly based on Caucasian and Japanese populations. This study investigated Taiwanese patients with WASP mutations since 1985 as part of a long-term comprehensive study in primary immunodeficiency diseases (PIDs) covering 23 million inhabitants.
METHODS: Clinical manifestations, immunologic functions, and WASP gene sequencing and expressions were analyzed in WAS patients. And, those patients with idiopathic thrombocytopenic purpura and "small" thrombocytopenia were enrolled.
RESULTS: Of 16 patients studied in 1993-2009, 12 presented as classic WAS phenotype and four had X-linked thrombocytopenia (XLT). Almost all correlated to the WASP expression level and severity of infections. Causes of mortality in the 12 classic WAS patients were mass bleeding, Staphylococcus aureus sepsis, and cytomegalovirus (CMV) pneumonitis in three non-transplant cases, and EBV-associated lymphoproliferative disorder and CMV pneumonitis in two non-engrafted transplant patients. Splicing mutations of Int 8 (+5) G>A in cousins and insertion of 1023 C in unrelated families presented as both XLT and classic WAS phenotype in the same mutations. Four XLT patients, including two novel mutations of 1023 Ins C (in 2) and "double" missense mutations of 1378 C>T and 1421 T>C had relatively higher CD4+ memory cells and/or activated lymphocytes (CD3+CD69+) compared with those of classic WAS patients.
CONCLUSIONS: The lower ratio of XLT to classic WAS patients underestimates the burden of Taiwanese patients with WASP mutations, especially the XLT phenotype. A clustering pattern on exon 1 and five unique mutations (deletion of 45-48 ACCA, IVS 1 (-1) G>C, large deletion of promoter and exon 1 and 2, insertion 1023 C, and 1378 C>T and 1421 T>C) explain the genetic variations in different ethnic groups, despite the possibility of selection and ascertainment bias.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232122     DOI: 10.1007/s10875-010-9381-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  40 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  Hans D Ochs
Journal:  Isr Med Assoc J       Date:  2002-05       Impact factor: 0.892

2.  Takayasu's arteritis associated with Wiskott-Aldrich syndrome.

Authors:  Y L Lau; S N Wong; W M Lawton
Journal:  J Paediatr Child Health       Date:  1992-10       Impact factor: 1.954

Review 3.  WASp in immune-system organization and function.

Authors:  Adrian J Thrasher
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

4.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 5.  Current classification and status of primary immunodeficiency diseases in Taiwan.

Authors:  Fang-Chen Liang; Yi-Chia Wei; Tang-Her Jiang; Meng-Ying Hsiehi; Yu-Chuan Wen; Yi-Shiou Chiou; Shu-Hua Wu; Li-Chen Chen; Jing-Long Huang; Wen-I Lee
Journal:  Acta Paediatr Taiwan       Date:  2008 Jan-Feb

6.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 7.  Mechanisms of WASp-mediated hematologic and immunologic disease.

Authors:  Siobhan Burns; Giles O Cory; William Vainchenker; Adrian J Thrasher
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

8.  Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.

Authors:  Marsilio Adriani; Joseph Aoki; Reiko Horai; Angela M Thornton; Akihiro Konno; Martha Kirby; Stacie M Anderson; Richard M Siegel; Fabio Candotti; Pamela L Schwartzberg
Journal:  Clin Immunol       Date:  2007-05-18       Impact factor: 3.969

9.  Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

Authors:  Hulya Ozsahin; Marina Cavazzana-Calvo; Luigi D Notarangelo; Ansgar Schulz; Adrian J Thrasher; Evelina Mazzolari; Mary A Slatter; Francoise Le Deist; Stephane Blanche; Paul Veys; Anders Fasth; Robbert Bredius; Petr Sedlacek; Nico Wulffraat; Juan Ortega; Carsten Heilmann; Anne O'Meara; Jacek Wachowiak; Krzysztof Kalwak; Susanne Matthes-Martin; Tayfun Gungor; Aydan Ikinciogullari; Paul Landais; Andrew J Cant; Wilhelm Friedrich; Alain Fischer
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

10.  Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.

Authors:  J Y Park; M Kob; A P Prodeus; F S Rosen; A Shcherbina; E Remold-O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

View more
  4 in total

1.  A case of familial X-linked thrombocytopenia with a novel WAS gene mutation.

Authors:  Eu Kyoung Lee; Yeun-Joo Eem; Nack-Gyun Chung; Myung Shin Kim; Dae Chul Jeong
Journal:  Korean J Pediatr       Date:  2013-06-21

2.  Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene.

Authors:  Takashi Ohya; Masakatsu Yanagimachi; Kentaro Iwasawa; Shuichiro Umetsu; Tsuyoshi Sogo; Ayano Inui; Tomoo Fujisawa; Shuichi Ito
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

3.  Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.

Authors:  Deepti Suri; Rashmi Rikhi; Ankur K Jindal; Amit Rawat; Murugan Sudhakar; Pandiarajan Vignesh; Anju Gupta; Anit Kaur; Jyoti Sharma; Jasmina Ahluwalia; Prateek Bhatia; Alka Khadwal; Revathi Raj; Ramya Uppuluri; Mukesh Desai; Prasad Taur; Ambreen A Pandrowala; Vijaya Gowri; Manisha R Madkaikar; Harsha Prasada Lashkari; Sagar Bhattad; Harish Kumar; Sanjeev Verma; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Koon W Chan; Pamela P Lee; Yu Lung Lau; Surjit Singh
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

4.  Application of high-throughput sequencing for hereditary thrombocytopenia in southwestern China.

Authors:  Luying Zhang; Jie Yu; Ying Xian; Xianhao Wen; Xianmin Guan; Yuxia Guo; Mingzhu Luo; Ying Dou
Journal:  J Clin Lab Anal       Date:  2021-07-08       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.